244229-52-5Relevant academic research and scientific papers
Synthesis, characterization, and biological relevance of hydroxypyrone and hydroxypyridinone complexes of molybdenum
Lord, Sarah J.,Epstein, Noah A.,Paddock, Robert L.,Vogels, Christopher M.,Hennigar, Tracy L.,Zaworotko, Michael J.,Taylor, Nicholas J.,Driedzic, William R.,Broderick, Tom L.,Westcott, Stephen A.
, p. 1249 - 1261 (2007/10/03)
We have prepared a number of complexes of the type cis-MoO2L2 where L represents a hydroxypyronato or hydroxypyridinonato ligand. Both the maltol (3-hydroxy-2-methyl-4-pyrone, Hma) and kojic acid (5-hydroxy-2-hydroxymethyl-4-pyrone, Hka) complexes, cis-MoO2(ma)2 (1) and cis-MoO2(ka)2 (2), have been characterized by X-ray diffraction studies. The pyrone ligands are bound to molybdenum in a cis bidentate fashion via the deprotonated hydroxyl groups and the ketone moieties. Crystals of 1 are orthorhombic, a = 12.107 (1), b = 8.6169 (8), c = 16.472 (1) A, Z = 4, space group Pca21, and those of 2 are monoclinic, a = 8.4591 (5), b = 16.3453 (10), c = 10.2954 (7) A, β = 103.0320 (10)°, Z = 4, space group P21/c. Hydroxypyridinone molybdenum complexes have been prepared for both maltol and kojic acid derivatives with the substituents Me, n-Pr, CH2Ph, Ph at the ring nitrogen. Crystals of the 3-hydroxy-2-methyl-1-phenyl-4-pyridinone (Hppp) derivative, MoO2(ppp)2 (9), are monoclinic, a = 10.9476 (6), b = 13.5353 (9), c = 17.4877 (10) A, β = 93.465 (4)°, Z = 4, space group P21/n. Initial investigations into the effects molybdenum compounds have on diabetic hearts are presented. Both Na2MoO4 (used as a control) and 1 were effective in lowering blood glucose and free fatty acid levels. Diabetic rats treated with molybdate showed significant improvements in postischemic cardiac function.
